p53, mdm2, EGFR, and msh2 expression in paired initial and recurrent glioblastoma multiforme.
about
Different molecular patterns in glioblastoma multiforme subtypes upon recurrenceMolecular alterations in glioblastoma: potential targets for immunotherapy.Combined Flt3L/TK gene therapy induces immunological surveillance which mediates an immune response against a surrogate brain tumor neoantigen.Oligodendrocyte/type-2 astrocyte progenitor cells and glial-restricted precursor cells generate different tumor phenotypes in response to the identical oncogenes.Phase-1 trial of gefitinib and temozolomide in patients with malignant glioma: a North American brain tumor consortium study.A comprehensive profile of recurrent glioblastoma.Protein Analysis of Glioblastoma Primary and Posttreatment Pairs Suggests a Mesenchymal Shift at Recurrence.The expression of mismatch repair proteins MLH1, MSH2 and MSH6 correlates with the Ki67 proliferation index and survival in patients with recurrent glioblastoma.DNA-repair gene variants are associated with glioblastoma survival.Recurrent Glioblastomas Exhibit Higher Expression of Biomarkers with Stem-like Properties.Assessment of PD-1 positive cells on initial and secondary resected tumor specimens of newly diagnosed glioblastoma and its implications on patient outcome.A NOVEL AND EFFICIENT ALGORITHM FOR DE NOVO DISCOVERY OF MUTATED DRIVER PATHWAYS IN CANCER.Expression of DNA mismatch repair proteins MLH1, MSH2, and MSH6 in recurrent glioblastoma.Gene therapy and targeted toxins for gliomaThe p53 Pathway in Glioblastoma
P2860
Q33611551-2B23540D-A4A9-4F94-8724-3AF68516FC02Q34870511-F7898463-F159-4946-8598-9B76BAB8926EQ35285859-C47D2D94-898D-42DA-B405-D5EDA7A6F5E9Q37231529-628D2991-DFCE-4485-AF5B-710AFD3C7592Q37414810-90AC7C96-C9E8-427C-8C14-E94C278E0A6AQ38797345-91E41FD3-3A80-4408-A3AF-548C355DD209Q39475779-E219027A-29D8-45BE-A7CE-3919ECFD105FQ43133266-196AC4A9-90C6-4E3F-899A-207DE05B1ADAQ48827117-2EE5CD2F-B4D5-4A35-8FDF-136CF62A159DQ49883157-81A33AF1-5EB8-4032-8A38-B34364EF3710Q52097229-5518F38F-92DC-474A-B7B5-D83733AC0189Q52686022-51B7A8C3-DE7D-483A-A5CD-32B5F2A2D50DQ54199829-3757C446-AE2C-4439-B22D-45A4C854A742Q57006162-6E7478D9-3987-4585-8FD7-925E33E61019Q57162865-1477DBD0-263B-48E7-886B-A0D1A6F5839F
P2860
p53, mdm2, EGFR, and msh2 expression in paired initial and recurrent glioblastoma multiforme.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
p53, mdm2, EGFR, and msh2 expr ...... rrent glioblastoma multiforme.
@ast
p53, mdm2, EGFR, and msh2 expr ...... rrent glioblastoma multiforme.
@en
type
label
p53, mdm2, EGFR, and msh2 expr ...... rrent glioblastoma multiforme.
@ast
p53, mdm2, EGFR, and msh2 expr ...... rrent glioblastoma multiforme.
@en
prefLabel
p53, mdm2, EGFR, and msh2 expr ...... rrent glioblastoma multiforme.
@ast
p53, mdm2, EGFR, and msh2 expr ...... rrent glioblastoma multiforme.
@en
P2093
P2860
P356
P1476
p53, mdm2, EGFR, and msh2 expr ...... rrent glioblastoma multiforme.
@en
P2093
P2860
P304
P356
10.1136/JNNP.74.6.779
P407
P577
2003-06-01T00:00:00Z